Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients

Cinzia BORGOGNA; Riccardo Bruna; Gloria Griffante; Licia Martuscelli; Marco De Andrea; Daniela FERRANTE; Andrea Patriarca; Abdurraouf Mokhtar Mahmoud; Maghalie Anais Marie Ucciero; Valentina Gaidano; Monia Marchetti; Davide Rapezzi; Michele Lai; Mauro Pistello; Marco LADETTO; Massimo Massaia; Gianluca GAIDANO; Marisa GARIGLIO

doi:10.1111/bjh.18429

Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients

Cinzia BORGOGNA
, Riccardo Bruna
, Gloria Griffante
, Licia Martuscelli
, Marco De Andrea
, Daniela FERRANTE
, Andrea Patriarca
, Abdurraouf Mokhtar Mahmoud
, Maghalie Anais Marie Ucciero
, Valentina Gaidano
, Monia Marchetti
, Davide Rapezzi
, Michele Lai
, Mauro Pistello
, Marco LADETTO
, Massimo Massaia
, Gianluca GAIDANO
, Marisa GARIGLIO

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Lingua originale	Inglese
pagine (da-a)	463-467
Numero di pagine	5
Rivista	British Journal of Haematology
Volume	199
Numero di pubblicazione	3
DOI	https://doi.org/10.1111/bjh.18429
Stato di pubblicazione	Pubblicato - 2022

Keywords

Antibodies, Viral
COVID-19
Hematologic Neoplasms
Humans
Immunity, Cellular
Immunity, Humoral
SARS-CoV-2
Vaccination
Vaccines

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1111/bjh.18429

http://hdl.handle.net/11579/145480

Altri file e collegamenti

handle

Cita questo

BORGOGNA, C., Bruna, R., Griffante, G., Martuscelli, L., De Andrea, M., FERRANTE, D., Patriarca, A., Mahmoud, A. M., Ucciero, M. A. M., Gaidano, V., Marchetti, M., Rapezzi, D., Lai, M., Pistello, M., LADETTO, M., Massaia, M., GAIDANO, G., & GARIGLIO, M. (2022). Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients. British Journal of Haematology, 199(3), 463-467. https://doi.org/10.1111/bjh.18429

@article{fd0cdc7b5f6d483fa4a67eb9d9e8c15f,

title = "Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients",

keywords = "Antibodies, Viral, COVID-19, Hematologic Neoplasms, Humans, Immunity, Cellular, Immunity, Humoral, SARS-CoV-2, Vaccination, Vaccines, Antibodies, Viral, COVID-19, Hematologic Neoplasms, Humans, Immunity, Cellular, Immunity, Humoral, SARS-CoV-2, Vaccination, Vaccines",

author = "Cinzia BORGOGNA and Riccardo Bruna and Gloria Griffante and Licia Martuscelli and \{De Andrea\}, Marco and Daniela FERRANTE and Andrea Patriarca and Mahmoud, \{Abdurraouf Mokhtar\} and Ucciero, \{Maghalie Anais Marie\} and Valentina Gaidano and Monia Marchetti and Davide Rapezzi and Michele Lai and Mauro Pistello and Marco LADETTO and Massimo Massaia and Gianluca GAIDANO and Marisa GARIGLIO",

note = "Funding Information: This work was supported by Associazione Italiana per la Ricerca sul Cancro Foundation Milan, Italy “Molecular bases of disease dissemination in lymphoid malignancies to optimize curative therapeutic strategies” (5 x 1000 No. 21198 to Gi.Ga.) and partially by the IG 21744 to Ma.Ma.; the AGING Project, Department of Excellence, DIMET, University of Piemonte Orientale, Novara, Italy to M.G. and Gi.Ga.; Ricerca Finalizzata 2018 (project RF‐2018‐12365790 to Gi.Ga.), MoH, Rome, Italy; Ministry for University ‐MUR‐ (PRIN 2017 to M.G., C.B. and M.P.; PRIN 2020 to M.G. and M.P.). We thank the UPO Biobank for its support for blood processing and storage. We are grateful to Sean P.J. Whelan for providing the rVSV‐SARS‐CoV‐2‐S. We acknowledge Associazione Italiana controle leucemie (AIL), Asti Alessandria and Regione Piemonte Bando INFRA‐P2: projects BSL3‐NTA (cod. 377‐4) and SURVEIL (cod. 378‐50). We thank Marcello Arsura for critically reviewing the manuscript. We acknowledge Operetta High Content Facility, CISUP, Centre for Instrumentation Sharing, University of Pisa. The authors thank Valeria Caneparo at CAAD, Center for Translational Research and Autoimmune and Allergic Disease,for assistance in the ELISA assay. Δ21 Funding Information: This work was supported by Associazione Italiana per la Ricerca sul Cancro Foundation Milan, Italy “Molecular bases of disease dissemination in lymphoid malignancies to optimize curative therapeutic strategies” (5 x 1000 No. 21198 to Gi.Ga.) and partially by the IG 21744 to Ma.Ma.; the AGING Project, Department of Excellence, DIMET, University of Piemonte Orientale, Novara, Italy to M.G. and Gi.Ga.; Ricerca Finalizzata 2018 (project RF-2018-12365790 to Gi.Ga.), MoH, Rome, Italy; Ministry for University -MUR- (PRIN 2017 to M.G., C.B. and M.P.; PRIN 2020 to M.G. and M.P.). We thank the UPO Biobank for its support for blood processing and storage. We are grateful to Sean P.J. Whelan for providing the rVSV-SARS-CoV-2-SΔ21. We acknowledge Associazione Italiana controle leucemie (AIL), Asti Alessandria and Regione Piemonte Bando INFRA-P2: projects BSL3-NTA (cod. 377-4) and SURVEIL (cod. 378-50). We thank Marcello Arsura for critically reviewing the manuscript. We acknowledge Operetta High Content Facility, CISUP, Centre for Instrumentation Sharing, University of Pisa. The authors thank Valeria Caneparo at CAAD, Center for Translational Research and Autoimmune and Allergic Disease,for assistance in the ELISA assay.",

year = "2022",

doi = "10.1111/bjh.18429",

language = "English",

volume = "199",

pages = "463--467",

journal = "British Journal of Haematology",

issn = "1365-2141",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

BORGOGNA, C, Bruna, R, Griffante, G, Martuscelli, L, De Andrea, M, FERRANTE, D, Patriarca, A, Mahmoud, AM, Ucciero, MAM, Gaidano, V, Marchetti, M, Rapezzi, D, Lai, M, Pistello, M, LADETTO, M, Massaia, M, GAIDANO, G & GARIGLIO, M 2022, 'Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients', British Journal of Haematology, vol. 199, n. 3, pagg. 463-467. https://doi.org/10.1111/bjh.18429

TY - JOUR

T1 - Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients

AU - BORGOGNA, Cinzia

AU - Bruna, Riccardo

AU - Griffante, Gloria

AU - Martuscelli, Licia

AU - De Andrea, Marco

AU - FERRANTE, Daniela

AU - Patriarca, Andrea

AU - Mahmoud, Abdurraouf Mokhtar

AU - Ucciero, Maghalie Anais Marie

AU - Gaidano, Valentina

AU - Marchetti, Monia

AU - Rapezzi, Davide

AU - Lai, Michele

AU - Pistello, Mauro

AU - LADETTO, Marco

AU - Massaia, Massimo

AU - GAIDANO, Gianluca

AU - GARIGLIO, Marisa

N1 - Funding Information: This work was supported by Associazione Italiana per la Ricerca sul Cancro Foundation Milan, Italy “Molecular bases of disease dissemination in lymphoid malignancies to optimize curative therapeutic strategies” (5 x 1000 No. 21198 to Gi.Ga.) and partially by the IG 21744 to Ma.Ma.; the AGING Project, Department of Excellence, DIMET, University of Piemonte Orientale, Novara, Italy to M.G. and Gi.Ga.; Ricerca Finalizzata 2018 (project RF‐2018‐12365790 to Gi.Ga.), MoH, Rome, Italy; Ministry for University ‐MUR‐ (PRIN 2017 to M.G., C.B. and M.P.; PRIN 2020 to M.G. and M.P.). We thank the UPO Biobank for its support for blood processing and storage. We are grateful to Sean P.J. Whelan for providing the rVSV‐SARS‐CoV‐2‐S. We acknowledge Associazione Italiana controle leucemie (AIL), Asti Alessandria and Regione Piemonte Bando INFRA‐P2: projects BSL3‐NTA (cod. 377‐4) and SURVEIL (cod. 378‐50). We thank Marcello Arsura for critically reviewing the manuscript. We acknowledge Operetta High Content Facility, CISUP, Centre for Instrumentation Sharing, University of Pisa. The authors thank Valeria Caneparo at CAAD, Center for Translational Research and Autoimmune and Allergic Disease,for assistance in the ELISA assay. Δ21 Funding Information: This work was supported by Associazione Italiana per la Ricerca sul Cancro Foundation Milan, Italy “Molecular bases of disease dissemination in lymphoid malignancies to optimize curative therapeutic strategies” (5 x 1000 No. 21198 to Gi.Ga.) and partially by the IG 21744 to Ma.Ma.; the AGING Project, Department of Excellence, DIMET, University of Piemonte Orientale, Novara, Italy to M.G. and Gi.Ga.; Ricerca Finalizzata 2018 (project RF-2018-12365790 to Gi.Ga.), MoH, Rome, Italy; Ministry for University -MUR- (PRIN 2017 to M.G., C.B. and M.P.; PRIN 2020 to M.G. and M.P.). We thank the UPO Biobank for its support for blood processing and storage. We are grateful to Sean P.J. Whelan for providing the rVSV-SARS-CoV-2-SΔ21. We acknowledge Associazione Italiana controle leucemie (AIL), Asti Alessandria and Regione Piemonte Bando INFRA-P2: projects BSL3-NTA (cod. 377-4) and SURVEIL (cod. 378-50). We thank Marcello Arsura for critically reviewing the manuscript. We acknowledge Operetta High Content Facility, CISUP, Centre for Instrumentation Sharing, University of Pisa. The authors thank Valeria Caneparo at CAAD, Center for Translational Research and Autoimmune and Allergic Disease,for assistance in the ELISA assay.

PY - 2022

Y1 - 2022

KW - Antibodies, Viral

KW - COVID-19

KW - Hematologic Neoplasms

KW - Humans

KW - Immunity, Cellular

KW - Immunity, Humoral

KW - SARS-CoV-2

KW - Vaccination

KW - Vaccines

KW - Antibodies, Viral

KW - COVID-19

KW - Hematologic Neoplasms

KW - Humans

KW - Immunity, Cellular

KW - Immunity, Humoral

KW - SARS-CoV-2

KW - Vaccination

KW - Vaccines

UR - https://iris.uniupo.it/handle/11579/145480

U2 - 10.1111/bjh.18429

DO - 10.1111/bjh.18429

M3 - Article

SN - 1365-2141

VL - 199

SP - 463

EP - 467

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 3

ER -